NCT05872568View on ClinicalTrials.gov

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Kidney Transplant Rejection

Interventions

DRUG

Enteric-Coated Mycophenolate Sodium (EC-MPS)

The recommended dose range is 360 to 720mg,bid

All Listed Sponsors

lead

Zhishui Chen

OTHER